MedTrace Logo

An Observational Study of Patients With Moderate Parkinson's Disease

NCT05779475 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 96

Last updated 2025-12-24

No results posted yet for this study

Summary

The main purpose of this study is to follow and observe a group of people living with Parkinson's disease to see how study participation affects their signs and symptoms in the months after starting in the study. While taking part in this study participants will take their usual medication as prescribed. However, the study doctor may recommend adjustments to their medication to provide a better treatment of their Parkinson's disease. Participation will last from 3 up to 24 months. During visits to the clinic, the study doctor or study nurse will evaluate signs and symptoms of Parkinson's disease using several different assessments. At a minimum of 2 visits participants will be asked to undergo 'off'-assessments.

Conditions

  • Parkinson Disease

Interventions

OTHER

No treatment given

Participants will not receive any investigational treatment in this study.

Sponsors & Collaborators

Principal Investigators

  • Clinical Transparency dept. 2834 · Novo Nordisk A/S

Eligibility

Min Age
50 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-05
Primary Completion
2030-03-11
Completion
2030-03-11

Countries

  • United States
  • Japan
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05779475 on ClinicalTrials.gov